Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001946362 | SCV002207627 | uncertain significance | RYR1-related disorder | 2022-03-08 | criteria provided, single submitter | clinical testing | This variant, c.1120_1122del, results in the deletion of 1 amino acid(s) of the RYR1 protein (p.Lys374del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs745569223, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002492006 | SCV002800801 | uncertain significance | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-10-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV005051938 | SCV005685931 | likely pathogenic | not provided | 2024-07-23 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; In-frame deletion of 1 amino acids in a non-repeat region; This variant is associated with the following publications: (PMID: 33767344) |